ArticleOncotarget2016

Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.

Andrea M Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.